Recent Finacing
Recent Raise
Cardurion Pharmaceuticals is a clinical-stage biotech developing PDE9 and CaMKII inhibitors for heart failure and arrhythmias, conducting Phase 2 trials and operating discovery facilities in Massachusetts and Shonan, Japan.
